HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siyi Xu Selected Research

Interferons

12/2023A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population.
1/2023miR-548c-3p targets TRIM22 to attenuate the Peg-IFN-α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B.
12/2022IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro.
11/2022Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapy.
1/2021Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siyi Xu Research Topics

Disease

16Neoplasms (Cancer)
12/2023 - 11/2013
5Traumatic Brain Injuries (Traumatic Brain Injury)
08/2023 - 07/2015
4Melanoma (Melanoma, Malignant)
12/2023 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
01/2023 - 07/2018
4Chronic Hepatitis B
01/2023 - 01/2021
3Neoplasm Metastasis (Metastasis)
01/2024 - 01/2018
3Stroke (Strokes)
01/2024 - 01/2020
3Infections
12/2023 - 01/2021
2Stomach Neoplasms (Stomach Cancer)
02/2024 - 11/2017
2Ischemic Stroke
01/2024 - 01/2020
2Breast Neoplasms (Breast Cancer)
10/2023 - 10/2023
2Brain Edema (Cerebral Edema)
08/2023 - 11/2018
2Glioma (Gliomas)
04/2022 - 01/2022
2Genomic Instability
04/2022 - 01/2021
2Memory Disorders (Memory Loss)
01/2021 - 08/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2024
1Epilepsy (Aura)
01/2024
1Lentivirus Infections
12/2023
1Cognitive Dysfunction
01/2023
1Nervous System Diseases (Neurological Disorders)
01/2023
1Hepatitis B
12/2022
1Mitochondrial Diseases (Mitochondrial Disease)
03/2022
1Infertility (Sterility)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
11/2021
1Alzheimer Disease (Alzheimer's Disease)
08/2020
1Inflammation (Inflammations)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2020
1Adenocarcinoma of Lung
01/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2019
1Papillary Thyroid Cancer
01/2018
1Carcinogenesis
01/2018
1Carcinoma (Carcinomatosis)
11/2017

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2018
7Long Noncoding RNAIBA
01/2019 - 11/2017
6Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2017
5InterferonsIBA
12/2023 - 01/2021
5MicroRNAs (MicroRNA)IBA
01/2021 - 01/2018
3Hepatitis B e AntigensIBA
01/2023 - 01/2019
3RNA (Ribonucleic Acid)IBA
04/2022 - 11/2021
3Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
11/2018 - 07/2015
2LipidsIBA
01/2024 - 12/2023
2InflammasomesIBA
12/2023 - 01/2023
26-methyladenineIBA
01/2023 - 11/2021
2Interferon-alpha (Interferon Alfa)IBA
12/2022 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
04/2022 - 01/2019
2Amyloid (Amyloid Fibrils)IBA
01/2021 - 08/2020
2Peptides (Polypeptides)IBA
08/2020 - 04/2016
2Glutamic Acid (Glutamate)FDA Link
11/2018 - 04/2016
1NitrosaminesIBA
02/2024
1Aminobutyrates (Aminobutyric Acid)IBA
01/2024
1Apolipoproteins E (ApoE)IBA
01/2024
1Carrier Proteins (Binding Protein)IBA
01/2024
1CholesterolIBA
01/2024
1gamma-Aminobutyric Acid (GABA)IBA
01/2024
1growth arrest-specific protein 6IBA
01/2024
1Pentylenetetrazole (Metrazol)IBA
01/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023
1CD40 Ligand (CD40L)IBA
12/2023
1Adenosine Triphosphate (ATP)IBA
12/2023
1PerforinIBA
12/2023
1PuromycinIBA
12/2023
1Granzymes (Granzyme)IBA
12/2023
1Estrogen ReceptorsIBA
10/2023
1Histone Deacetylase InhibitorsIBA
08/2023
1SilverIBA
08/2023
1VorinostatFDA Link
08/2023
1Complement System Proteins (Complement)IBA
01/2023
1Adenosine Triphosphatases (ATPase)IBA
01/2023
1CationsIBA
01/2023
1Antiviral Agents (Antivirals)IBA
12/2022
1Flap EndonucleasesIBA
04/2022
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
04/2022
1Transcription Factors (Transcription Factor)IBA
03/2022
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2022
1NADP (NADPH)IBA
01/2022
1Histone Deacetylase 1IBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1Oxidoreductases (Dehydrogenase)IBA
01/2022
1N-methyladenosineIBA
11/2021
1Taurocholic Acid (Sodium Taurocholate)IBA
01/2021
1Therapeutic UsesIBA
08/2020
1xingnaojingIBA
08/2020
1Excitatory Amino AcidsIBA
08/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1Mitogen-Activated Protein KinasesIBA
01/2020
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019
1Neuroprotective AgentsIBA
11/2018
1N-acetylaspartate (N-acetyl aspartate)IBA
11/2018
1Competitive Endogenous RNAIBA
01/2018
1Messenger RNA (mRNA)IBA
11/2017

Therapy/Procedure

9Therapeutics
10/2023 - 11/2017
2Immunotherapy
01/2023 - 01/2022
1Precision Medicine
02/2024
1Nephrectomy
01/2024
1Ligation
04/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2020
1Treatment Delay
01/2020